Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?

Tilray announced a consolidation of its Canadian operations expected to generate $10 million in annual cost savings, leading to slightly raised adjusted EBITDA guidance for fiscal 2027 ($70-75 million vs. previous $68-75 million). However, the company continues to burn cash and faces challenges in the competitive Canadian cannabis market with low margins. Analysts remain cautious, suggesting investors take a wait-and-see approach as the improvements are insufficient to make the stock a compelling buy.